Drugs / Secretomes
Trials 1 · a red edge is where a trial was stopped
| Phase | Registry id | Dates | Indication | Sponsor | Status | Outcome |
|---|---|---|---|---|---|---|
| Phase 1/2 | NCT05279768 | Sep 2022 → Jan 2025 | polycystic ovary syndrome | PT. Prodia Stem Cell Indonesia | Completed | No outcome recorded |
Evidence & citations 2 cited values
Every value below carries the sentence it was read from. 1 source stands behind the page.
| Field | Value | Cited text |
|---|---|---|
| Known as | Secretomes | ClinicalTrials.gov intervention name — accepted as the source's own label NCT05279768 ↗ |
| Route | Intranasal | “nasal drop 0.5 ml/day (Secretomes) for 30 days” NCT05279768 ↗ |